Cannabix Files Breath Sample Capture Patent And Detects Delta-8 THC In Early Testing
Portfolio Pulse from Vuk Zdinjak
Cannabix Technologies Inc. has filed an International Patent Application for its breath sample capture technology, which has detected delta-9 THC in early testing. The company is in discussions with forensic laboratory organizations to integrate its technology into current testing methods. This comes as California's employment laws change, prohibiting employers from making decisions based on the presence of non-psychoactive cannabis metabolites in drug screening.
August 04, 2023 | 3:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cannabix's new patent application and successful early testing of its technology could potentially increase its market value. The changes in California's employment laws could also create a larger market for its product.
The filing of a new patent and successful early testing of Cannabix's technology indicates potential growth and innovation in the company. The changes in California's employment laws could lead to increased demand for Cannabix's product, as employers will need to test for recent cannabis use rather than long-term metabolites. This could potentially increase Cannabix's market value.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100